REV1 Inhibition Enhances Radioresistance and Autophagy
Cancer therapy resistance is a persistent clinical challenge. Recently, inhibition of the mutagenic translesion synthesis (TLS) protein REV1 was shown to enhance tumor cell response to chemotherapy by triggering senescence hallmarks. These observations suggest REV1’s important role in determining ca...
Guardado en:
Autores principales: | Kanayo E. Ikeh, Erica N. Lamkin, Andrew Crompton, Jamie Deutsch, Kira J. Fisher, Mark Gray, David J. Argyle, Won Y. Lim, Dmitry M. Korzhnev, M. Kyle Hadden, Jiyong Hong, Pei Zhou, Nimrat Chatterjee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8b30413ff89465cb626e026f8c27cf5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma
por: Xiao J, et al.
Publicado: (2021) -
REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model
por: Shangyi Wang, et al.
Publicado: (2021) -
Determination of representative elementary volume (REV) for jointed rock masses exhibiting scale-dependent behavior: a numerical investigation
por: Mehmet Sari
Publicado: (2021) -
HPLC DETERMINATION OF ETOPOSIDE IN INJECTABLE DOSAGE FORMS
por: MUNAWAR HAYAT,M, et al.
Publicado: (2011) -
Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
por: Alberto Aranza-Martínez, et al.
Publicado: (2021)